Bryant David Lim is SVP AND GENERAL COUNSEL at IDERA PHARMACEUTICALS, INC. (IDRA). They have made 6 open-market trades across 2 companies since 2018, most recently 2024-12-19.
CIK 0001752888
3 open-market purchases totalling $48K since 2018, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | BUY | 2024-12-19 | 2024-12-20 | $0.91 | $23K | +6.5% | -6.5% | -43.6% |
| PRLD | BUY | 2023-05-24 | 2023-05-25 | $5.39 | $13K | +9.2% | -14.9% | -34.2% |
| IDRA | SELL | 2021-03-25 | 2021-03-29 | $1.36 | $10K | +2.3% | -4.6% | -0.8% |
| IDRA | SELL | 2021-01-12 | 2021-01-12 | $4.21 | $7K | +40.4% | +20.0% | -71.8% |
| IDRA | SELL | 2021-01-05 | 2021-01-11 | $3.91 | $6K | +40.0% | +23.8% | -71.8% |
| IDRA | SELL · 10b5-1 | 2020-01-07 | 2020-01-14 | $1.78 | $3K | -6.8% | -18.4% | -13.7% |
| IDRA | BUY | 2018-12-21 | 2018-12-26 | $3.05 | $12K | +17.7% | -13.9% | -18.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.